Dysregulation of immune checkpoint molecules as a characteristic of autoimmune congenital heart block

Ann Rheum Dis. 2024 Oct 21;83(11):1598-1600. doi: 10.1136/ard-2024-226176.

Ana-Luisa Stefanski^{1

2}, Hector Rincon-Arevalo^{3

2

4

5}, Iris Dressler-Steinbach⁶, Nadja Nomovi^{6

7}, Alma Mackert⁶, Arman Aue⁵, Jacob Ritter^{3

2}, Annika Wiedemann^{3

2}, Franziska Szelinski^{3

2}, Eva Schrezenmeier^{2

5}, Anja A Kühl⁸, Andreia C Lino², Wolfgang Henrich⁶, Thomas Dörner^{3

2}

¹ Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin, Berlin, Germany ana-luisa.stefanski@charite.de.
² Deutsches Rheuma-Forschungszentrum (DRFZ), Berlin, Germany.
³ Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin, Berlin, Germany.
⁴ Immunologia cellular e immunogenetica, Universidad de Antioquia, Medellin, Colombia.
⁵ Department of Nephrology and Intensive Medical Care, Charité Universitätsmedizin, Berlin, Germany.
⁶ Department of Obstetrics, Charite Universitätsmedizin, Berlin, Germany.
⁷ Department of Obstetrics, Ernst von Bergmann Hospital, Potsdam, Brandenburg, Germany.
⁸ iPATH, Core Unit of Charité, Charité Universitätsmedizin, Berlin, Germany.

No abstract available

Keywords: Autoantibodies; Child; Sjogren's Syndrome.

Publication types